ACLX logo

Arcellx (ACLX)

Profile

Full Name

Arcellx, Inc.

Ticker Symbol

ACLX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 4, 2022

Indexes

Not included

Website

http://www.arcellx.com

Employees

163

Key Details

Price

$64.06

Market Cap

$3.52B(Mid cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$107.94M(-2.16% YoY)

Annual EPS

-$2.00(-36.05% YoY)

PE Ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$64.06
ACLX price is $64.06

Price All-time High

$108.50
ACLX price is currently -40.96% below its historical high of $108.50

Price Today Change

-3.28%
ACLX price is down -3.28% today

Price YTD Change

-20.45%
ACLX price is down -20.45% since January 1st

Price 1-year Change

+1.35%
ACLX price is up +1.35% year-on-year

Price 3-year Change

+345.45%
ACLX price is up +345.45% over the past 3 years

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market Cap

$3.52B
ACLX market capitalization is $3.52 billion

Market Cap 3-year Change

+585.2%
ACLX market capitalization is up +585.2% over the past 3 years

Market Cap All-time High

$5.87B
ACLX market capitalization is currently -40.01% below its historical high of $5.87 billion

Market Cap Sector Rank

87.61%
ACLX market capitalization is higher than 87.61% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+3.11%
ACLX shares outstanding is up +3.11% year-on-year

Shares Outstanding 3-Year Change

+53.82%
ACLX shares outstanding is up +53.82% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.69
ACLX beta is 1.69

200-day SMA

$72.64
ACLX price is currently -11.82% below its 200-day simple moving average

50-day SMA

$66.83
ACLX price is currently -4.16% below its 50-day simple moving average

RSI

48.28
ACLX 14-day relative strength index is 48.28

Volume

0.87
ACLX 30-day relative volume is 0.87

ATR

$4.15
ACLX average true range is $4.15

10-day Historical Volatility

79.26%
ACLX 10-day historical volatility is 79.26%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$107.94M
ACLX annual revenue is $107.94 million

Revenue Analysts Estimate

$88.18M
ACLX annual revenue is currently +22.41% higher than the consensus analysts' forecast

Revenue 1-year Change

-2.16%
ACLX annual revenue is down -2.16% year-on-year

Revenue Sector Rank

58.62%
ACLX annual revenue is higher than 58.62% of companies in Healthcare sector

EPS

EPS

-$2.00
ACLX annual earnings per share is -$2.00

EPS Analysts Estimate

-$3.10
ACLX annual earnings per share is currently -35.45% lower than the consensus analysts' forecast

EPS 1-year Change

-36.05%
ACLX annual earnings per share is down -36.05% year-on-year

EPS Sector Rank

38.1%
ACLX annual earnings per share is higher than 38.1% of companies in Healthcare sector

Profit

Gross Profit

-
ACLX annual gross profit value is unknown

Gross Margin

-
ACLX annual gross profit margin value is unknown

Operating Profit

-$137.57M
ACLX annual operating income is -$137.57 million

Operating Margin

-127.46%
ACLX annual operating profit margin is -127.46%

Net Income

-$107.35M
ACLX annual net profit is -$107.35 million

Net Margin

-99.46%
ACLX annual net profit margin is -99.46%

Expenses

Total Expenses

$245.51M
ACLX annual total expenses is $245.51 million

Operating Expenses

$245.51M
ACLX annual total operating expenses is $245.51 million

Cost Of Goods Sold

-
ACLX annual cost of goods sold value is unknown

Selling, General & Administrative Expenses

$88.41M
ACLX annual SGA is $88.41 million

Depreciation And Amortization

$5.19M
ACLX annual depreciation & amortization is $5.19 million

Interest Expense

$1.03M
ACLX annual interest expense is $1.03 million

Income Tax

$2.07M
ACLX annual income tax is $2.07 million

EBIT & EBITDA

EBIT

-$104.25M
ACLX annual earnings before interest & taxes is -$104.25 million

EBITDA

-$99.06M
ACLX annual EBITDA is -$99.06 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total Assets

$711.33M
ACLX annual total assets is $711.33 million

Non Current Assets

$112.02M
ACLX annual long term assets is $112.02 million

Current Assets

$599.31M
ACLX annual total current assets is $599.31 million

Cash And Cash Equivalents

$105.68M
ACLX annual cash & cash equivalents is $105.68 million

Accounts Receivable

-
ACLX annual accounts receivable value is unknown

Inventory

-
ACLX annual inventory value is unknown

Liabilities

Total Liabilities

$256.54M
ACLX annual total liabilities is $256.54 million

Long Term Liabilities

$131.13M
ACLX annual total long term liabilities is $131.13 million

Current Liabilities

$125.41M
ACLX annual total current liabilities is $125.41 million

Accounts Payable

$2.10M
ACLX annual accounts payable is $2.10 million

Debt

Total Debt

$54.08M
ACLX annual total debt is $54.08 million

Total Debt 1-year Change

-44.6%
ACLX annual total debt is down -44.6% year-on-year

Long Term Debt

$46.54M
ACLX annual long term debt is $46.54 million

Short Term Debt

$7.54M
ACLX annual short term debt is $7.54 million

Equity & Capital

Shareholders Equity

$454.79M
ACLX annual stockholders equity is $454.79 million

Book Value

$454.79M
ACLX annual book value is $454.79 million

Retained Earnings

-$496.83M
ACLX annual retained earnings is -$496.83 million

Working Capital

$473.90M
ACLX annual working capital is $473.90 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash From Operations

-$83.47M
ACLX annual cash flow from operations is -$83.47 million

Cash From Operations 1-year Change

-140.21%
ACLX annual cash flow from operations is down -140.21% year-on-year

Cash From Investing

-$183.04M
ACLX annual cash flow from investing activities is -$183.04 million

Cash From Investing 1-year Change

-18.47%
ACLX annual cash flow from investing activities is down -18.47% year-on-year

Cash From Financing

-$24.09M
ACLX annual cash flow from financing activities is -$24.09 million

Cash From Financing 1-year Change

-108.63%
ACLX annual cash flow from financing activities is down -108.63% year-on-year

CAPEX

CAPEX

$13.43M
ACLX annual capital expenditures is $13.43 million

CAPEX 1-year Change

-37.31%
ACLX annual capital expenditures is down -37.31% year-on-year

Free Cash Flow

Free Cash Flow

-$96.90M
ACLX annual free cash flow is -$96.90 million

Free Cash Flow 1-year Change

-152.06%
ACLX annual free cash flow is down -152.06% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross Margin

-
ACLX annual gross profit margin value is unknown

Operating Margin

-127.46%
ACLX annual operating profit margin is -127.46%

Net Margin

-99.46%
ACLX annual net profit margin is -99.46%

ROA & ROE

ROA

-13.97%
ACLX annual return on assets is -13.97%

ROE

-22.84%
ACLX annual return on equity is -22.84%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
ACLX price to earnings ratio value is unknown

PE Ratio Sector Rank

-
ACLX price to earnings ratio is unknown

PB Ratio

PB Ratio

7.74
ACLX price to book ratio is 7.74

PB Ratio Sector Rank

89.98%
ACLX price to book ratio is higher than 89.98% of companies in Healthcare sector

PS Ratio

PS Ratio

32.61
ACLX price to sales ratio is 32.61

PS Ratio Sector Rank

89.5%
ACLX price to sales ratio is higher than 89.5% of companies in Healthcare sector

Enterprise value

Enterprise Value

$3.47B
ACLX enterprise value is $3.47 billion

Enterprise Value Sector Rank

86.02%
ACLX enterprise value is higher than 86.02% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-35.01
ACLX EV/EBITDA is -35.01

EV/EBITDA Sector Rank

4.27%
ACLX EV/EBITDA is higher than 4.27% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current Ratio

4.78
ACLX annual current ratio is 4.78

Quick Ratio

-
ACLX annual quick ratio value is unknown

Leverage

Debt To Equity

0.00
ACLX annual debt to equity ratio is 0.00

Interest Coverage Ratio

-101.21
ACLX annual interest coverage ratio is -101.21

Risk & Stability

Piotroski F-Score

-
ACLX piotroski f-score value is unknown

Altman Z-Score

7.72
ACLX altman z-score is 7.72

Analyst ratings

Recent major analysts updates

Dec 10, 24 UBS
Buy
Dec 10, 24 Needham
Buy
Dec 10, 24 HC Wainwright & Co.
Buy
Dec 9, 24 Needham
Buy
Nov 12, 24 Truist Securities
Buy
Nov 8, 24 Piper Sandler
Overweight
Nov 8, 24 Needham
Buy
Nov 8, 24 HC Wainwright & Co.
Buy
Nov 6, 24 Needham
Buy
Nov 6, 24 Morgan Stanley
Overweight

Institutional Ownership

Similar stocks

ICUI logo
ICU Medical (ICUI)
ALHC logo
Alignment Healthcare (ALHC)
RNA logo
Avidity Biosciences (RNA)
OSCR logo
Oscar Health (OSCR)
PTCT logo
PTC Therapeutics (PTCT)
SLNO logo
Soleno Therapeutics (SLNO)
RDNT logo
RadNet (RDNT)
PRGO logo
Perrigo (PRGO)
SWTX logo
SpringWorks Therapeutics (SWTX)
  • What is the ticker symbol for Arcellx?
  • Does Arcellx pay dividends?
  • What sector is Arcellx in?
  • What industry is Arcellx in?
  • What country is Arcellx based in?
  • When did Arcellx go public?
  • Is Arcellx in the S&P 500?
  • Is Arcellx in the NASDAQ 100?
  • Is Arcellx in the Dow Jones?
  • When was Arcellx's last earnings report?
  • When does Arcellx report earnings?
  • Should I buy Arcellx stock now?

What is the ticker symbol for Arcellx?

The ticker symbol for Arcellx is NASDAQ:ACLX

Does Arcellx pay dividends?

No, Arcellx does not pay dividends

What sector is Arcellx in?

Arcellx is in the Healthcare sector

What industry is Arcellx in?

Arcellx is in the Biotechnology industry

What country is Arcellx based in?

Arcellx is headquartered in United States

When did Arcellx go public?

Arcellx's initial public offering (IPO) was on February 4, 2022

Is Arcellx in the S&P 500?

No, Arcellx is not included in the S&P 500 index

Is Arcellx in the NASDAQ 100?

No, Arcellx is not included in the NASDAQ 100 index

Is Arcellx in the Dow Jones?

No, Arcellx is not included in the Dow Jones index

When was Arcellx's last earnings report?

Arcellx's most recent earnings report was on Feb 27, 2025

When does Arcellx report earnings?

The next expected earnings date for Arcellx is May 9, 2025

Should I buy Arcellx stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page